A complex molecular machine, the spliceosome, ensures that the genetic information from the genome, after being transcribed ...

A complex molecular machine, the spliceosome, ensures that the genetic information from the genome, after being transcribed ...

Maravai Lifesciences Holdings Inc (MRVI) stock has reached a new 52-week low, touching down at $4.19, representing a steep 64% decline from its 52-week high of $11.55. The $1.09 billion market cap ...

In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...

a key building block in mRNA manufacturing.” He continued: “OriCiro’s technology strategically complements our manufacturing expertise and further accelerates our research and development ...

“Alchemy is Aldevron’s exclusive cell-free DNA technology which cuts research grade linear DNA manufacturing time by over 50 percent, accelerating mRNA development projects with ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

The deal is analogous to the UK's earlier decade-long agreement with Moderna, which centred on a manufacturing facility for mRNA vaccines, mainly targeting infectious diseases, along with R&D ...

TriLink BioTechnologies, a Maravai LifeSciences (MRVI) company and global provider of life science reagents and services, has signed a ...